Variant report
Variant | nsv511476 |
---|---|
Chromosome Location | chr11:46161054-46169659 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:49)
- CpG islands (count:244)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:49 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF2 | chr11:46163144-46163395 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr11:46163214-46163478 | GM12878 | blood: | n/a | n/a |
3 | BATF | chr11:46163206-46163510 | GM12878 | blood: | n/a | n/a |
4 | BCL11A | chr11:46163165-46163442 | GM12878 | blood: | n/a | n/a |
5 | BHLHE40 | chr11:46163346-46163520 | GM12878 | blood: | n/a | n/a |
6 | CEBPB | chr11:46165622-46165866 | HepG2 | liver: | n/a | chr11:46165793-46165804 |
7 | CEBPB | chr11:46165781-46165805 | IMR90 | lung: | n/a | chr11:46165793-46165804 |
8 | CTCF | chr11:46166500-46166650 | Hela-S3 | cervix: | n/a | chr11:46166518-46166531 |
9 | CTCF | chr11:46164820-46164970 | HepG2 | liver: | n/a | n/a |
10 | CTCF | chr11:46166469-46166573 | GM19239 | blood: | n/a | chr11:46166518-46166531 |
11 | CTCF | chr11:46166455-46166569 | GM12878 | blood: | n/a | chr11:46166518-46166531 |
12 | CTCF | chr11:46166500-46166560 | H1-hESC | embryonic stem cell: | n/a | chr11:46166518-46166531 |
13 | CTCF | chr11:46164849-46164860 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | CTCF | chr11:46166453-46166598 | Gliobla | brain: | n/a | chr11:46166518-46166531 |
15 | CTCF | chr11:46166473-46166536 | MCF-7 | breast: | n/a | chr11:46166518-46166531 |
16 | CTCF | chr11:46164862-46164914 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | CTCF | chr11:46166460-46166610 | HPF | lung: | n/a | chr11:46166518-46166531 |
18 | CTCF | chr11:46166512-46166545 | GM19240 | blood: | n/a | chr11:46166518-46166531 |
19 | CTCF | chr11:46166494-46166558 | GM12892 | blood: | n/a | chr11:46166518-46166531 |
20 | CTCF | chr11:46164854-46164915 | MCF-7 | breast: | n/a | n/a |
21 | CTCF | chr11:46166440-46166590 | HepG2 | liver: | n/a | chr11:46166518-46166531 |
22 | CTCF | chr11:46166474-46166525 | Fibrobl | skin: | n/a | n/a |
23 | IRF4 | chr11:46163231-46163541 | GM12878 | blood: | n/a | n/a |
24 | JUN | chr11:46168317-46168460 | H1-hESC | embryonic stem cell: | n/a | n/a |
25 | MEF2A | chr11:46163162-46163522 | GM12878 | blood: | n/a | n/a |
26 | MYC | chr11:46166465-46166538 | MCF-7 | breast: | n/a | n/a |
27 | MYC | chr11:46166453-46166565 | MCF-7 | breast: | n/a | n/a |
28 | MYC | chr11:46166443-46166450 | MCF-7 | breast: | n/a | n/a |
29 | MYC | chr11:46166576-46166580 | MCF-7 | breast: | n/a | n/a |
30 | MYC | chr11:46164701-46164765 | MCF-7 | breast: | n/a | n/a |
31 | MYC | chr11:46164697-46164747 | MCF-7 | breast: | n/a | n/a |
32 | NFIC | chr11:46163132-46163564 | GM12878 | blood: | n/a | n/a |
33 | POLR2A | chr11:46164747-46164753 | MCF-7 | breast: | n/a | n/a |
34 | POLR2A | chr11:46166331-46166575 | MCF-7 | breast: | n/a | n/a |
35 | POLR2A | chr11:46165077-46165276 | Gliobla | brain: | n/a | n/a |
36 | POLR2A | chr11:46164775-46164800 | MCF-7 | breast: | n/a | n/a |
37 | POLR2A | chr11:46164725-46164727 | MCF-7 | breast: | n/a | n/a |
38 | POLR2A | chr11:46164812-46164817 | MCF-7 | breast: | n/a | n/a |
39 | POLR2A | chr11:46164583-46164599 | MCF-7 | breast: | n/a | n/a |
40 | POLR2A | chr11:46164625-46164646 | MCF-7 | breast: | n/a | n/a |
41 | POLR2A | chr11:46166370-46166635 | MCF-7 | breast: | n/a | n/a |
42 | POLR2A | chr11:46165112-46165214 | MCF-7 | breast: | n/a | n/a |
43 | POLR2A | chr11:46163418-46163665 | MCF-7 | breast: | n/a | n/a |
44 | RFX5 | chr11:46161352-46161536 | HepG2 | liver: | n/a | n/a |
45 | RUNX3 | chr11:46163228-46163488 | GM12878 | blood: | n/a | n/a |
46 | RUNX3 | chr11:46163141-46163582 | GM12878 | blood: | n/a | n/a |
47 | STAT3 | chr11:46168183-46168383 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | TBP | chr11:46164927-46164928 | H1-hESC | embryonic stem cell: | n/a | n/a |
49 | ZNF143 | chr11:46166485-46166531 | H1-hESC | embryonic stem cell: | n/a | chr11:46166491-46166506 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:46164652-46164702 | AG04449 | skin: | fetal |
2 | chr11:46166409-46166459 | AG09319 | gingival: | n/a |
3 | chr11:46164796-46164846 | NB4 | blood: | n/a |
4 | chr11:46164774-46164824 | HRCEpiC | kidney: | n/a |
5 | chr11:46164774-46164824 | SK-N-MC | brain: | n/a |
6 | chr11:46166409-46166459 | A549 | lung: | n/a |
7 | chr11:46166409-46166459 | PrEC | prostate: | n/a |
8 | chr11:46164774-46164824 | Caco-2 | colon: | n/a |
9 | chr11:46164774-46164824 | SAEC | small airway: | n/a |
10 | chr11:46164796-46164846 | HUVEC | blood vessel: | n/a |
11 | chr11:46164652-46164702 | HNPCEpiC | eye: | n/a |
12 | chr11:46164652-46164702 | SK-N-SH_RA | brain: | n/a |
13 | chr11:46164796-46164846 | AG09319 | gingival: | n/a |
14 | chr11:46164796-46164846 | Hepatocyte | liver: | n/a |
15 | chr11:46164796-46164846 | K562 | blood: | n/a |
16 | chr11:46166409-46166459 | GM12878 | blood: | n/a |
17 | chr11:46164652-46164702 | MCF10A-Er-Src | breast: | n/a |
18 | chr11:46164796-46164846 | RPTEC | kidney: | n/a |
19 | chr11:46164796-46164846 | GM12892 | blood: | n/a |
20 | chr11:46164796-46164846 | Hela-S3 | cervix: | n/a |
21 | chr11:46164774-46164824 | NT2-D1 | testis: | n/a |
22 | chr11:46164796-46164846 | HRE | kidney: | n/a |
23 | chr11:46164796-46164846 | HEK293 | kidney: | embryo |
24 | chr11:46164774-46164824 | PFSK-1 | brain: | n/a |
25 | chr11:46164796-46164846 | HL-60 | blood: | n/a |
26 | chr11:46166409-46166459 | U87 | brain: | n/a |
27 | chr11:46164774-46164824 | IMR90 | lung: | fetal |
28 | chr11:46166409-46166459 | SKMC | muscle: | n/a |
29 | chr11:46164774-46164824 | BE2_C | brain: | n/a |
30 | chr11:46166409-46166459 | HNPCEpiC | eye: | n/a |
31 | chr11:46164652-46164702 | Hela-S3 | cervix: | n/a |
32 | chr11:46164796-46164846 | HNPCEpiC | eye: | n/a |
33 | chr11:46164774-46164824 | SK-N-SH_RA | brain: | n/a |
34 | chr11:46164774-46164824 | ProgFib | skin: | n/a |
35 | chr11:46164796-46164846 | HPAEpiC | pulmonary alveolar: | n/a |
36 | chr11:46164796-46164846 | HAEpiC | amniotic membrane: | n/a |
37 | chr11:46164652-46164702 | BE2_C | brain: | n/a |
38 | chr11:46166409-46166459 | HRE | kidney: | n/a |
39 | chr11:46164774-46164824 | NB4 | blood: | n/a |
40 | chr11:46164652-46164702 | HPAEpiC | pulmonary alveolar: | n/a |
41 | chr11:46166409-46166459 | GM12891 | blood: | n/a |
42 | chr11:46164652-46164702 | AG09309 | skin: | n/a |
43 | chr11:46166409-46166459 | NHBE | bronchial: | n/a |
44 | chr11:46166409-46166459 | CMK | blood: | n/a |
45 | chr11:46166409-46166459 | HCM | heart: | n/a |
46 | chr11:46164774-46164824 | HMEC | breast: | n/a |
47 | chr11:46164796-46164846 | BJ | skin: | n/a |
48 | chr11:46166409-46166459 | MCF-7 | breast: | n/a |
49 | chr11:46166409-46166459 | GM06990 | blood: | n/a |
50 | chr11:46164774-46164824 | AG04449 | skin: | fetal |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:46147849..46150697-chr11:46169653..46172751,3 | MCF-7 | breast: | |
2 | chr11:46161878..46163896-chr11:46165531..46168198,2 | K562 | blood: | |
3 | chr11:46159444..46162124-chr11:46222416..46223935,2 | K562 | blood: | |
4 | chr11:46156833..46159429-chr11:46159952..46162455,2 | K562 | blood: | |
5 | chr11:46161878..46163896-chr11:46165531..46168198,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000254871 | TF binding region |
ENSG00000254871 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576883304 | chr11:46161366-46161367 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs192396983 | chr11:46161388-46161389 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs113717698 | chr11:46161390-46161391 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs561123566 | chr11:46161391-46161392 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs561068220 | chr11:46161394-46161395 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs147165468 | chr11:46161403-46161404 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs546598521 | chr11:46161408-46161409 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs138504164 | chr11:46161417-46161418 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs532934756 | chr11:46161485-46161486 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs183658080 | chr11:46161511-46161512 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs563153183 | chr11:46163135-46163136 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs572575040 | chr11:46163140-46163141 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs184892721 | chr11:46163184-46163185 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs562744174 | chr11:46163206-46163207 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs548788847 | chr11:46163241-46163242 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs568701707 | chr11:46163255-46163256 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs529790927 | chr11:46163256-46163257 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs546645119 | chr11:46163301-46163302 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs566458487 | chr11:46163435-46163436 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs541304676 | chr11:46163438-46163439 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs558271402 | chr11:46163457-46163458 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs568807034 | chr11:46163487-46163488 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs537783878 | chr11:46163488-46163489 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs191075817 | chr11:46163508-46163509 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs574265566 | chr11:46163521-46163522 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs11038777 | chr11:46163538-46163539 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs554200759 | chr11:46163560-46163561 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs55860723 | chr11:46163572-46163573 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs183212653 | chr11:46163598-46163599 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs116651031 | chr11:46163615-46163616 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs562908425 | chr11:46163623-46163624 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs186011589 | chr11:46163624-46163625 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs191498590 | chr11:46163645-46163646 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs562387615 | chr11:46163655-46163656 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs527850415 | chr11:46163690-46163691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs144341216 | chr11:46163712-46163713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs533149615 | chr11:46163736-46163737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs35094884 | chr11:46163743-46163744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549813035 | chr11:46163749-46163750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563537512 | chr11:46163795-46163796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537470998 | chr11:46164027-46164028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112098252 | chr11:46164050-46164051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568025700 | chr11:46164067-46164068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188032926 | chr11:46164081-46164082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531698954 | chr11:46164132-46164133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs377092238 | chr11:46164133-46164134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7924340 | chr11:46164157-46164158 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs35313668 | chr11:46164158-46164159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539580670 | chr11:46164166-46164167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539637876 | chr11:46164182-46164183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Parathyroid adenoma | 22454399 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21364760 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Melanoma | 18172304 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Potocki-Shaffer syndrome | 22470819 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 16608533 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Breast cancer | 20409316 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:46163200-46163800 | Enhancers | GM12878-XiMat | blood |
2 | chr11:46164000-46164400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr11:46164200-46164400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr11:46164400-46164600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr11:46164400-46164600 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr11:46164400-46164600 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
7 | chr11:46164400-46164800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr11:46164600-46165400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr11:46164600-46170800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr11:46164800-46170800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr11:46165400-46170400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr11:46166400-46166600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr11:46166400-46166600 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
14 | chr11:46166400-46166600 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
15 | chr11:46166400-46166600 | Enhancers | A549 | lung |
16 | chr11:46166400-46167000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
17 | chr11:46169000-46169200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr11:46169200-46171000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |